Clinical Trial Update: The HIt HArd and hiT Early in Multiple Sclerosis Trial [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for Relapsing-remitting multiple sclerosis led by Uppsala University, currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Snippet

Sponsor: Uppsala University | Conditions: Relapsing-remitting Multiple Sclerosis | Phase 2 | Status: NOT_YET_RECRUITING